Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sercan Aksoy

Showing results (161-170 of 206) with videos related to

Pageof 21
Sort By:
Immunotherapy|June 27, 2025
Albumin-myosteatosis gauge as a prognostic biomarker in patients treated with immune checkpoint inhibitorsTaha Koray Sahin, Deniz Can Guven, Yakup Ozbay, et al.
Biomarkers in Medicine|August 16, 2021
Lower prognostic nutritional index is associated with poorer survival in patients receiving immune checkpoint inhibitorsDeniz C Guven, Oktay H Aktepe, Hakan Taban, et al.
Cancer Research|February 6, 2024
Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast CancerMustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 12, 2021
Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapyDeniz Can Guven, Melek Seren Aksun, Taha Koray Sahin, et al.
Cancers|March 13, 2024
Sonographic Measurements of Rectus Femoris Muscle Thickness Strongly Predict Neutropenia in Cancer Patients Receiving ChemotherapyGürkan Güner, Levent Özçakar, Yusuf Baytar, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|December 24, 2014
Outcome of 561 non-metastatic triple negative breast cancer patients: multi-center experience from TurkeyBurcin Budakoglu, Kadri Altundag, Sercan Aksoy, et al.
Biomarkers in Medicine|April 12, 2023
Evaluation of sarcopenia as a prognostic biomarker in locally advanced head and neck squamous cell carcinomaEnes Erul, Deniz C Guven, Yakup Ozbay, et al.
Medical Oncology (Northwood, London, England)|June 23, 2012
Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patientsEmin Tamer Elkiran, Mehmet Ali Kaplan, Alper Sevinc, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 22, 2014
Recurrence risk and prognostic parameters in stage I rectal cancersSener Cihan, Mehmet Kucukoner, Nuriye Ozdemir, et al.
International Journal of Cancer|September 9, 2022
Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapyDeniz Can Guven, Fatma Gul Gulbahce Incesu, Hasan Cagri Yildirim, et al.
Pageof 21

Showing results (161-170 of 206) with videos related to

Sort By:
Pageof 21
Immunotherapy|June 27, 2025
Albumin-myosteatosis gauge as a prognostic biomarker in patients treated with immune checkpoint inhibitorsTaha Koray Sahin, Deniz Can Guven, Yakup Ozbay, et al.
Biomarkers in Medicine|August 16, 2021
Lower prognostic nutritional index is associated with poorer survival in patients receiving immune checkpoint inhibitorsDeniz C Guven, Oktay H Aktepe, Hakan Taban, et al.
Cancer Research|February 6, 2024
Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast CancerMustafa Emre Gedik, Ozge Saatci, Nathaniel Oberholtzer, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 12, 2021
Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapyDeniz Can Guven, Melek Seren Aksun, Taha Koray Sahin, et al.
Cancers|March 13, 2024
Sonographic Measurements of Rectus Femoris Muscle Thickness Strongly Predict Neutropenia in Cancer Patients Receiving ChemotherapyGürkan Güner, Levent Özçakar, Yusuf Baytar, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|December 24, 2014
Outcome of 561 non-metastatic triple negative breast cancer patients: multi-center experience from TurkeyBurcin Budakoglu, Kadri Altundag, Sercan Aksoy, et al.
Biomarkers in Medicine|April 12, 2023
Evaluation of sarcopenia as a prognostic biomarker in locally advanced head and neck squamous cell carcinomaEnes Erul, Deniz C Guven, Yakup Ozbay, et al.
Medical Oncology (Northwood, London, England)|June 23, 2012
Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patientsEmin Tamer Elkiran, Mehmet Ali Kaplan, Alper Sevinc, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 22, 2014
Recurrence risk and prognostic parameters in stage I rectal cancersSener Cihan, Mehmet Kucukoner, Nuriye Ozdemir, et al.
International Journal of Cancer|September 9, 2022
Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapyDeniz Can Guven, Fatma Gul Gulbahce Incesu, Hasan Cagri Yildirim, et al.
Pageof 21